$SCOR

COMSCORE, INC.

CIK:0001158172|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Jun. 30, 2026

Jun. 30, 2025

Income Statement [Abstract]

Revenues

^[1],[2]

$ 79,246

$ 89,389

$ 164,568

$ 175,098

Cost of revenues

^{[1],[2],[3],[4],[5]}

50,982

53,099

103,970

104,846

Selling and marketing

^[3],[4],[5]

14,778

16,663

30,434

31,466

Research and development

^[3],[4],[5]

7,154

7,804

14,940

15,922

General and administrative

^[3],[4],[5]

14,998

12,872

27,778

25,347

Amortization of intangible assets

632

1,264

Loss on divestiture of business, net

2,682

Total expenses from operations

91,226

91,070

181,068

178,845

Loss from operations

(11,980)

(1,681)

(16,500)

(3,747)

Gain (loss) from foreign currency transactions

520

(3,803)

1,760

(5,546)

Other income, net

417

Interest expense, net

(1,021)

(1,553)

(2,771)

(3,311)

Loss on extinguishment of debt

(3,608)

(3,970)

Loss before income taxes

(15,672)

(7,037)

(21,064)

(12,604)

Income tax benefit (provision)

887

(2,455)

(881)

Net loss

(14,785)

(9,492)

(21,033)

(13,485)

Net loss available to common stockholders:

Net loss

(14,785)

(9,492)

(21,033)

(13,485)

Convertible redeemable preferred stock dividends

^[1],[2]

(4,494)

(8,933)

Total net loss available to common stockholders

$ (14,785)

$ (13,986)

$ (21,033)

$ (22,418)

Net loss per common share:

Basic (in dollars per share)

$ (0.97)

$ (2.73)

$ (1.38)

$ (4.41)

Diluted (in dollars per share)

$ (0.97)

$ (2.73)

$ (1.38)

$ (4.41)

Weighted-average number of shares used in per share calculation - Common Stock:

Basic (in shares)

15,241,209

5,114,830

15,190,902

5,078,069

Diluted (in shares)

15,241,209

5,114,830

15,190,902

5,078,069

Comprehensive loss:

Net loss

$ (14,785)

$ (9,492)

$ (21,033)

$ (13,485)

Other comprehensive (loss) income:

Foreign currency cumulative translation adjustment

(548)

5,276

(2,489)

7,915

Total comprehensive loss

$ (15,333)

$ (4,216)

$ (23,522)

$ (5,570)

[1]


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025			2026		2025
Revenues	$	501	$	2,285		$	1,002	$	4,889
Cost of revenues	2,665		5,435			5,443		11,201
Convertible redeemable preferred stock dividends	—		(4,494)			—		(8,933)

[2]

(1) Transactions with related parties are included in the line items above as follows. Refer to Footnote 10, Related Party Transactions.

[3]


(2) Excludes amortization of intangible assets, which is presented as a separate line item.

(3) Stock-based compensation (benefit) expense is included in the line items above as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Cost of revenues	$	(144)	$	399	$	70	$	561
Selling and marketing	(40)		383		131		507
Research and development	(91)		239		36		336
General and administrative	186		727		499		1,082
Total stock-based compensation (benefit) expense	$	(89)	$	1,748	$	736	$	2,486

[4]

(2) Excludes amortization of intangible assets, which is presented as a separate line item.

[5]

(3) Stock-based compensation (benefit) expense is included in the line items above as follows:

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities:
Net loss	$ (21,033)	$ (13,485)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	11,749	11,674
Non-cash loss on extinguishment of debt	3,477	0
Non-cash operating lease expense	2,249	2,500
Amortization expense of finance leases	1,838	1,857
Amortization of intangible assets	1,264	1,264
Stock-based compensation expense	736	2,486
Gain on divestiture of business	(1,178)	0
Deferred tax (benefit) provision	(1,208)	538
Unrealized foreign currency gain	(2,272)	0
Other	1,142	1,311
Changes in operating assets and liabilities:
Accounts receivable	12,314	11,255
Prepaid expenses and other assets	(123)	(1,077)
Accounts payable, accrued expenses and other liabilities	3,316	515
Contract liabilities and customer advances	70	(4,460)
Operating lease liabilities	(4,300)	(4,384)
Net cash provided by operating activities	8,041	9,994
Investing activities:
Proceeds from divestiture of business, net of cash transferred	55,740	0
Purchases of property and equipment	(608)	(524)
Capitalized internal-use software costs	(11,674)	(10,868)
Net cash provided by (used in) investing activities	43,458	(11,392)
Financing activities:
Principal payments of term loan	(44,550)	(225)
Principal payments on finance leases	(1,977)	(1,609)
Principal payments on insurance financing	(1,293)	(1,321)
Payment of preferred stock and common stock issuance costs	(1,219)	0
Contingent consideration payment at initial value	0	(859)
Payment of financing and debt issuance costs	0	(559)
Other	(501)	(3)
Net cash used in financing activities	(49,540)	(4,576)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(12)	2,032
Net increase (decrease) in cash, cash equivalents and restricted cash	1,947	(3,942)
Cash, cash equivalents and restricted cash at beginning of period	26,800	33,468
Cash, cash equivalents and restricted cash at end of period	28,747	29,526
Cash and cash equivalents	25,707	25,993
Restricted cash	3,040	3,533
Total cash, cash equivalents and restricted cash	28,747	29,526
Supplemental cash flow disclosure:
Interest paid	2,146	2,658
Supplemental disclosures of non-cash investing and financing activities:
Divestiture escrow receivables and post-close adjustment receivable	4,844	0
Settlement of restricted stock unit liability	1,586	314
Modification of operating right-of-use assets	1,136	0
Change in accounts payable and accrued expenses related to capital expenditures	793	898
Series B convertible redeemable preferred stock dividends accrued but not yet paid (related parties)	0	8,933
Right-of-use assets obtained in exchange for finance lease liabilities	$ 0	$ 619

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 25,707	$ 23,621
Restricted cash	3,040	3,179
Accounts receivable, net of allowances of $292 and $496, respectively ($— and $1,019 of accounts receivable attributable to related parties, respectively)	44,078	57,260
Prepaid expenses and other current assets	15,001	12,210
Total current assets	87,826	96,270
Property and equipment, net	39,401	43,714
Operating right-of-use assets	5,095	8,565
Deferred tax assets	2,774	3,154
Intangible assets, net	1,264	2,529
Goodwill	185,347	248,636
Other non-current assets	5,823	4,841
Total assets	327,530	407,709
Current liabilities:
Accounts payable ($3,608 and $1,762 attributable to related parties, respectively)	17,693	16,956
Accrued expenses ($11,428 and $9,664 attributable to related parties, respectively)	43,432	44,879
Contract liabilities ($— and $754 attributable to related parties, respectively)	35,646	36,575
Customer advances	5,940	7,605
Current operating lease liabilities	7,621	8,783
Other current liabilities	4,847	8,093
Total current liabilities	115,179	122,891
Secured term loan	0	39,297
Non-current operating lease liabilities	1,694	6,238
Non-current portion of accrued data costs ($15,559 and $18,357 attributable to related parties, respectively)	22,098	24,917
Deferred tax liabilities	732	1,997
Total liabilities	148,408	206,548
Commitments and contingencies
Series C convertible redeemable preferred stock, $0.001 par value; 12,670,863 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025; aggregate liquidation preference of $183,728 as of June 30, 2026 and December 31, 2025 (related parties)	89,654	89,722
Stockholders' equity:
Preferred stock, $0.001 par value; 1,329,137 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued or outstanding as of June 30, 2026 or December 31, 2025	0	0
Common stock, $0.001 par value; 46,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 15,522,565 shares issued and 15,184,326 shares outstanding as of June 30, 2026, and 15,214,378 shares issued and 14,876,139 shares outstanding as of December 31, 2025	15	15
Additional paid-in capital	1,783,261	1,781,265
Accumulated other comprehensive loss	(12,796)	(9,862)
Accumulated deficit	(1,451,028)	(1,429,995)
Treasury stock, at cost, 338,239 shares as of June 30, 2026 and December 31, 2025	(229,984)	(229,984)
Total stockholders' equity	89,468	111,439
Total liabilities, convertible redeemable preferred stock and stockholders' equity	327,530	407,709
Related Party
Current assets:
Accounts receivable, net of allowances of $292 and $496, respectively ($— and $1,019 of accounts receivable attributable to related parties, respectively)	0	1,019
Current liabilities:
Accounts payable ($3,608 and $1,762 attributable to related parties, respectively)	3,608	1,762
Accrued expenses ($11,428 and $9,664 attributable to related parties, respectively)	11,428	9,664
Contract liabilities ($— and $754 attributable to related parties, respectively)	0	754
Non-current portion of accrued data costs ($15,559 and $18,357 attributable to related parties, respectively)	15,559	18,357
Other non-current liabilities	4,766	4,457
Nonrelated Party
Current liabilities:
Other non-current liabilities	$ 3,939	$ 6,751